M0224 Insurance Policy Changes

HCPCS M0224 is officially defined as "Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring." HCPCS M0224 is referenced in 2 tracked payer policy changes from Florida Blue and Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS M0224 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.